John Zalcberg
Monash University
H-index: 79
Oceania-Australia
Top articles of John Zalcberg
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with KIT … | John Raymond Zalcberg Jean-Yves Blay Ping Chi Robin Lewis Jones Cesar Serrano | 2024/1/20 | |
Cross-trial comparisons for the adjuvant treatment of MSI colorectal cancer: dare to dream the future scenarios. | European Journal of Cancer | Alessandro Pastorino Fabio Catalano John R Zalcberg Alberto Sobrero | 2024/3/1 |
Exploring patient reported quality of life in lung cancer patients: A qualitative study of patient‐reported outcome measures | Asia‐Pacific Journal of Clinical Oncology | Elena Jensen‐Marini Darshini Ayton John Zalcberg Robert G Stirling | 2024/3/23 |
Implementing Decentralized Clinical Trials in Australia through Teletrials: Where to From Here? | Therapeutic Innovation & Regulatory Science | Tanya Symons Anne Woollett John Zalcberg Lisa Eckstein | 2024/4/29 |
External validation of the ARCAD nomogram in a real-world cohort of patients with stage IV colorectal cancer (CRC). | James Yu Jiannong Li Michael Schell Pablo Gonzalez Ginestet John Raymond Zalcberg | 2024/1/20 | |
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal … | British Journal of Cancer | CS Karapetis H Liu MJ Sorich LD Pederson E Van Cutsem | 2024/2/24 |
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO. 17 and CO. 20 Randomized Clinical Trials | Clinical Cancer Research | Joao Paulo Solar Vasconcelos Nan Chen Emma Titmuss Dongsheng Tu Stephanie Y Brule | 2024/1/30 |
Abstract CT106: First-in-human phase 1 study of paclitaxel-eluting PTM-101 film in subjects with borderline resectable or locally advanced pancreatic cancers | Cancer Research | Charles Pilgrim Marty Smith Ee-Jun Ban Samantha Ellis John Zalcberg | 2024/4/5 |
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial | Nature medicine | Michael C Heinrich Robin L Jones Suzanne George Hans Gelderblom Patrick Schöffski | 2024/1/5 |
7P Molecular targeted therapies based on metastatic site in first-line treatment for colorectal cancer patients: An ARCAD pooled analysis | ESMO Open | M Raeisi R Cohen B Chibaudel H Hurwitz L Saltz | 2024/2/1 |
62P Updated overall survival and safety with ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib and harboring KIT … | ESMO Open | JY Blay RL Jones H Gelderblom S George P Schöffski | 2024/3/1 |
Medication reuse programs: a narrative review of the literature | Samuel Watts John Coutsouvelis Joanne Wickens Susan Poole Mia Percival | 2024/4/1 | |
Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia | Plos one | Sue M Evans Kris Ivanova Danca Cossio Charles HC Pilgrim Daniel Croagh | 2024/1/2 |
iCare – a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers … | BMC cancer | Patricia M Livingston Natalie Winter Anna Ugalde Liliana Orellana Antonina Mikocka-Walus | 2024/1/29 |
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP … | The Lancet Oncology | Sean McPhail Matthew E Barclay Shane A Johnson Ruth Swann Riaz Alvi | 2024/3/1 |
The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study | BMJ open | Bianka D'souza Anthony Glover Claire Bavor Benjamin Brown Rachael H Dodd | 2024/4/1 |
Overall survival and long-term safety with ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Final analyses … | John Raymond Zalcberg Robin Lewis Jones Jean-Yves Blay Suzanne George Hans Gelderblom | 2024/1/20 | |
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non … | European Journal of Cancer | Romain Cohen Morteza Raeisi Benoist Chibaudel Takayuki Yoshino Qian Shi | 2024/3/1 |
Differential impact of post-neoadjuvant stage on overall survival for surgically treated oesophageal cancer following neoadjuvant chemotherapy or chemoradiation: a … | Annals of Esophagus | Indika Gunadasa Nathan Papa Yin Li Khu Wendy Brown Paul Burton | 2024/3/25 |
Predictive and prognostic features of metastatic colorectal cancer arising from the transverse colon: A pooled analysis of the CCTG/AGITG CO. 17 and CO. 20 randomized trials. | Joao Paulo Solar Vasconcelos Nan Chen Dongsheng Tu Stephanie Yasmin Brule Rachel Anne Goodwin | 2023/2/1 |
